FR2361905A1 - Medicament pour la prevention et le traitement des infections provoquees par la pseudomonas aeruginosa et son procede de preparation - Google Patents

Medicament pour la prevention et le traitement des infections provoquees par la pseudomonas aeruginosa et son procede de preparation

Info

Publication number
FR2361905A1
FR2361905A1 FR7626119A FR7626119A FR2361905A1 FR 2361905 A1 FR2361905 A1 FR 2361905A1 FR 7626119 A FR7626119 A FR 7626119A FR 7626119 A FR7626119 A FR 7626119A FR 2361905 A1 FR2361905 A1 FR 2361905A1
Authority
FR
France
Prior art keywords
treatment
prevention
pseudomonas aeruginosa
infections caused
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7626119A
Other languages
English (en)
French (fr)
Other versions
FR2361905B1 (cg-RX-API-DMAC7.html
Inventor
Yuzuru Homma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Publication of FR2361905A1 publication Critical patent/FR2361905A1/fr
Application granted granted Critical
Publication of FR2361905B1 publication Critical patent/FR2361905B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7626119A 1976-02-05 1976-08-30 Medicament pour la prevention et le traitement des infections provoquees par la pseudomonas aeruginosa et son procede de preparation Granted FR2361905A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1086676A JPS5296731A (en) 1976-02-05 1976-02-05 Prophylactics and remedies of cyanomycosis

Publications (2)

Publication Number Publication Date
FR2361905A1 true FR2361905A1 (fr) 1978-03-17
FR2361905B1 FR2361905B1 (cg-RX-API-DMAC7.html) 1981-11-20

Family

ID=11762262

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7626119A Granted FR2361905A1 (fr) 1976-02-05 1976-08-30 Medicament pour la prevention et le traitement des infections provoquees par la pseudomonas aeruginosa et son procede de preparation

Country Status (7)

Country Link
US (1) US4120950A (cg-RX-API-DMAC7.html)
JP (1) JPS5296731A (cg-RX-API-DMAC7.html)
AT (1) AT343798B (cg-RX-API-DMAC7.html)
DE (1) DE2639012C3 (cg-RX-API-DMAC7.html)
DK (1) DK143249C (cg-RX-API-DMAC7.html)
FR (1) FR2361905A1 (cg-RX-API-DMAC7.html)
GB (1) GB1545862A (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
CA1247527A (en) * 1983-06-14 1988-12-28 Michael S. Collins High titer pseudomonas immune serum globulin
JPS6112629A (ja) * 1984-06-28 1986-01-21 Lion Corp 口腔内組成物
DE3508384A1 (de) * 1985-03-08 1986-11-06 Boehringer Mannheim Gmbh, 6800 Mannheim Hemmung humaner speichel- und pankreasamylase durch monoklonale antikoerper
GB8519848D0 (en) * 1985-08-07 1985-09-11 Schweiz Rotes Kreuz Treatment of chronic inflammatory disease
US4772465A (en) * 1986-10-27 1988-09-20 Miles Laboratories, Inc. Method of treating polymicrobial burn wound sepsis with a combination therapy of ciprofloxacin and pseudomonas immune globulin
RU2348425C2 (ru) * 2005-06-07 2009-03-10 ГНУ Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева Способ изготовления ассоциированной вакцины против стрептококкоза и псевдомоноза песцов и лисиц
RU2309767C1 (ru) * 2006-03-20 2007-11-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Способ изготовления вакцины против псевдомоноза свиней
RU2308288C1 (ru) * 2006-03-20 2007-10-20 Федеральное государственное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Вакцина поливалентная против псевдомоноза сельскохозяйственных животных
CN108138213A (zh) * 2015-02-20 2018-06-08 罗尔公司 控制蛋白酶产生的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947575A (en) * 1969-06-30 1976-03-30 E. R. Squibb & Sons, Inc. Peptides as argiotensin converting enzyme inhibitors
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum

Also Published As

Publication number Publication date
JPS5296731A (en) 1977-08-13
DK143249C (da) 1981-11-30
FR2361905B1 (cg-RX-API-DMAC7.html) 1981-11-20
DK143249B (da) 1981-08-03
ATA637776A (de) 1977-10-15
DE2639012B2 (de) 1978-08-03
US4120950A (en) 1978-10-17
GB1545862A (en) 1979-05-16
DK42677A (da) 1977-08-06
DE2639012C3 (de) 1979-06-28
DE2639012A1 (de) 1977-08-11
AT343798B (de) 1978-06-12
JPS546608B2 (cg-RX-API-DMAC7.html) 1979-03-30

Similar Documents

Publication Publication Date Title
GR900100481A (el) Μέ?οδος παρακευής υδατικού αιωρήματος για ουσιαστικά αδιάλυτους στο νερό ενεργούς παράγοντες.
EA200100524A1 (ru) Амиды антраниловой кислоты и их применение в качестве лекарственных средств
FI905956A0 (fi) Foerfarande foer producering av ett biologiskt aktivt protein.
MA20322A1 (fr) Nouveaux derives de n-(4-piperidinyl)-bicyclo condenses 2-imidozolamine et procede pour leur preparation
FR2361905A1 (fr) Medicament pour la prevention et le traitement des infections provoquees par la pseudomonas aeruginosa et son procede de preparation
FI902258A0 (fi) Menetelmä farmakologisesti aktiivisten 13,14-dihydro-17-fenyyli-18,19,20-trinor-PGF2 -alkyyliestereiden valmistamiseksi
TNSN97091A1 (fr) CONJUGUE PEG-IFN α PHYSIOLOGIQUEMENT ACTIF, PROCEDE POUR SA PREPARATION, COMPOSITIONS PHARMACEUTIQUES LE CONTENANT ET LEUR UTILISATION
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
FR2427329A1 (fr) Nouveaux derives d'acides phenoxyalkylcarboxyliques et leur application en therapeutique, notamment en tant qu'agents hypolipidemiants et hypocholesterolemiants
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
MA28289A1 (fr) Immunoglobulines
FR2373517A1 (fr) Pseudopeptides comportant le radical d'une molecule therapeutiquement active, utiles comme medicaments
FR2603107B1 (fr) Compositions, vaccin et anticorps monoclonaux utiles pour le traitement des affections par le virus hiv et procedes de production de ces anticorps et de diagnostic de la presence de ce virus
ATE215967T1 (de) Aus harn isolierte antikoagulierende verbindung
DE69824748D1 (de) Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen
FI101377B1 (fi) Menetelmä N-alkyloitujen 1,4-dihydropyridiiniyhdisteiden valmistamiseksi
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
IT1170913B (it) Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche
PT85317A (fr) Procede pour l:obtention d:imunotoxines par couplage d:un anticorps avec une proteine trichosanthine ou trickokirine
KR910005886A (ko) 안정화 백혈구 인터페론
DE69033306D1 (de) Proteinkomplex
FR2381053A1 (fr) Nouvelles oximes derivees de l'acide 3-thiadiazolyl thiomethyl 7-aminothiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
FR2400505A1 (fr) 1-phenylethanolamines anti-inflammatoires, compositions pharmaceutiques en comprenant et procedes pour les produire
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
FR2457275A1 (fr) Acides p-biphenyl-4 methyl-2 buten-3 oiques utiles dans le traitement des rhumatismes

Legal Events

Date Code Title Description
ST Notification of lapse